We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Novo Nordisk A/S NVO reported fourth-quarter 2024 earnings of 91 cents per American Depositary Receipt (ADR), which beat the ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

Regular, long-term use of alcohol has been shown to increase insulin resistance. The increase in blood sugar ... per deciliter (mg/dL), you'll need to down 15 grams of fast-acting carbohydrates. This ...

Fuel economy has always been a primary concern for new-car shoppers, and while hybrids do excel in this area, what really matters with a plug-in hybrid is the longest range it can achieve with ...